1. Home
  2. RDY vs SAM Comparison

RDY vs SAM Comparison

Compare RDY & SAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • SAM
  • Stock Information
  • Founded
  • RDY 1984
  • SAM 1984
  • Country
  • RDY India
  • SAM United States
  • Employees
  • RDY N/A
  • SAM N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • SAM Beverages (Production/Distribution)
  • Sector
  • RDY Health Care
  • SAM Consumer Staples
  • Exchange
  • RDY Nasdaq
  • SAM Nasdaq
  • Market Cap
  • RDY 2.1B
  • SAM 2.1B
  • IPO Year
  • RDY N/A
  • SAM 1995
  • Fundamental
  • Price
  • RDY $14.53
  • SAM $194.63
  • Analyst Decision
  • RDY Strong Buy
  • SAM Hold
  • Analyst Count
  • RDY 2
  • SAM 11
  • Target Price
  • RDY $16.95
  • SAM $271.70
  • AVG Volume (30 Days)
  • RDY 1.5M
  • SAM 298.7K
  • Earning Date
  • RDY 07-28-2025
  • SAM 07-24-2025
  • Dividend Yield
  • RDY 0.56%
  • SAM N/A
  • EPS Growth
  • RDY 1.47
  • SAM N/A
  • EPS
  • RDY 0.79
  • SAM 6.16
  • Revenue
  • RDY $3,809,801,863.00
  • SAM $2,040,741,000.00
  • Revenue This Year
  • RDY $10.24
  • SAM $2.79
  • Revenue Next Year
  • RDY N/A
  • SAM $2.61
  • P/E Ratio
  • RDY $18.39
  • SAM $31.63
  • Revenue Growth
  • RDY 16.61
  • SAM 0.79
  • 52 Week Low
  • RDY $12.26
  • SAM $185.34
  • 52 Week High
  • RDY $16.89
  • SAM $329.55
  • Technical
  • Relative Strength Index (RSI)
  • RDY 37.98
  • SAM 38.19
  • Support Level
  • RDY $14.81
  • SAM $191.44
  • Resistance Level
  • RDY $15.25
  • SAM $200.54
  • Average True Range (ATR)
  • RDY 0.20
  • SAM 6.64
  • MACD
  • RDY -0.12
  • SAM 1.26
  • Stochastic Oscillator
  • RDY 5.18
  • SAM 40.94

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About SAM Boston Beer Company Inc. (The)

Boston Beer is a top player in high-end malt beverages and adjacent categories in the US, with strong positions in craft beer, flavored malt beverages, hard cider, and hard seltzer. The bulk of volume and revenue is concentrated in four brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly. Beverages are produced using a hybrid model leveraging both in-house capacities and third-party breweries through contract arrangements. While the firm is required to use distributors to reach end markets, including retailers and on-premises operators, it also employs 500 internal sales representatives to educate the market about its products. The firm generates almost all sales in the US.

Share on Social Networks: